The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non‐alcoholic fatty liver disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|36|10|1549-1557

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.36, Iss.10, 2016-10, pp. : 1549-1557

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Macrophage activation marker soluble CD163 and non‐alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 8, 2015-08 ,pp. : 1293-1300

John Wiley & Sons Inc

Access to resources Recommend Favorite

Non-alcoholic fatty liver disease

By Smith Briohny W.   Adams Leon A.  

Critical Reviews in Clinical Laboratory Sciences, Vol. 48, Iss. 3, 2011-06 ,pp. : 97-113

Informa Healthcare

Access to resources Recommend Favorite

The macrophage activation marker sCD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children

By  

PEDIATRIC OBESITY, Vol. 10, Iss. 3, 2015-06 ,pp. : 226-233

John Wiley & Sons Inc

Access to resources Recommend Favorite

Orthotopic Liver Transplantation in Non-Alcoholic Fatty Liver Disease Patients

By  

Reviews on Recent Clinical Trials, Vol. 9, Iss. 3, 2014-09 ,pp. : 210-216

Bentham Science Publishers

Access to resources Recommend Favorite

Early menarche is associated with non‐alcoholic fatty liver disease in adulthood

By  

PEDIATRICS INTERNATIONAL, Vol. 59, Iss. 12, 2017-12 ,pp. : 1270-1275

John Wiley & Sons Inc

Access to resources Recommend Favorite